Biochemical Analysis of AKAP-Anchored PKA Signaling Complexes

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2022 Mar 14

PMID 35286684

Authors

Dominic P Byrne

Mitchell H Omar

Eileen J Kennedy

Patrick A Eyers

John D Scott

Affiliations

Soon will be listed here.

Abstract

Generation of the prototypic second messenger cAMP instigates numerous signaling events. A major intracellular target of cAMP is Protein kinase A (PKA), a Ser/Thr protein kinase. Where and when this enzyme is activated inside the cell has profound implications on the functional impact of PKA. It is now well established that PKA signaling is focused locally into subcellular signaling "islands" or "signalosomes." The A-Kinase Anchoring Proteins (AKAPs) play a critical role in this process by dictating spatial and temporal aspects of PKA action. Genetically encoded biosensors, small molecule and peptide-based disruptors of PKA signaling are valuable tools for rigorous investigation of local PKA action at the biochemical level. This chapter focuses on approaches to evaluate PKA signaling islands, including a simple assay for monitoring the interaction of an AKAP with a tunable PKA holoenzyme. The latter approach evaluates the composition of PKA holoenzymes, in which regulatory subunits and catalytic subunits can be visualized in the presence of test compounds and small-molecule inhibitors.

Citing Articles

Neuronal ER-plasma membrane junctions couple excitation to Ca-activated PKA signaling.

Vierra N, Ribeiro-Silva L, Kirmiz M, van der List D, Bhandari P, Mack O Nat Commun. 2023; 14(1):5231.

PMID: 37633939 PMC: 10460453. DOI: 10.1038/s41467-023-40930-6.

Classification of Cushing's syndrome PKAc mutants based upon their ability to bind PKI.

Omar M, Kihiu M, Byrne D, Lee K, Lakey T, Butcher E Biochem J. 2023; 480(12):875-890.

PMID: 37306403 PMC: 11136536. DOI: 10.1042/BCJ20230183.

Chemical signaling in the developing avian retina: Focus on cyclic AMP and AKT-dependent pathways.

Duarte-Silva A, Ximenes L, Guimaraes-Souza M, Domith I, Paes-de-Carvalho R Front Cell Dev Biol. 2022; 10:1058925.

PMID: 36568967 PMC: 9780464. DOI: 10.3389/fcell.2022.1058925.

Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart.

Zhu F, Wang Q, Wang Z, Zhang X, Zhang B, Wang H Oxid Med Cell Longev. 2022; 2022:5993459.

PMID: 36238650 PMC: 9553363. DOI: 10.1155/2022/5993459.

References

Gold M . Swimming regulations for protein kinase A catalytic subunit. Biochem Soc Trans. 2019; 47(5):1355-1366. DOI: 10.1042/BST20190230. View

Torheim E, Jarnaess E, Lygren B, Tasken K . Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling. Biochem J. 2009; 424(1):69-78. DOI: 10.1042/BJ20090933. View

DAVIES S, Reddy H, Caivano M, Cohen P . Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000; 351(Pt 1):95-105. PMC: 1221339. DOI: 10.1042/0264-6021:3510095. View

Iyer G, Moore M, Taylor S . Consequences of lysine 72 mutation on the phosphorylation and activation state of cAMP-dependent kinase. J Biol Chem. 2004; 280(10):8800-7. DOI: 10.1074/jbc.M407586200. View

Schwede F, Maronde E, Genieser H, Jastorff B . Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol Ther. 2000; 87(2-3):199-226. DOI: 10.1016/s0163-7258(00)00051-6. View

Scott J, Dessauer C, Tasken K . Creating order from chaos: cellular regulation by kinase anchoring. Annu Rev Pharmacol Toxicol. 2012; 53:187-210. PMC: 3540170. DOI: 10.1146/annurev-pharmtox-011112-140204. View

Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T . Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D.... J Biol Chem. 1990; 265(9):5267-72. View

Newlon M, Roy M, Morikis D, Carr D, Westphal R, Scott J . A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes. EMBO J. 2001; 20(7):1651-62. PMC: 145475. DOI: 10.1093/emboj/20.7.1651. View

Coghlan V, Hausken Z, Scott J . Subcellular targeting of kinases and phosphatases by association with bifunctional anchoring proteins. Biochem Soc Trans. 1995; 23(3):592-6. DOI: 10.1042/bst0230592. View

10.

Reed J, de Ropp J, Trewhella J, Glass D, Liddle W, Bradbury E . Conformational analysis of PKI(5-22)amide, the active inhibitory fragment of the inhibitor protein of the cyclic AMP-dependent protein kinase. Biochem J. 1989; 264(2):371-80. PMC: 1133591. DOI: 10.1042/bj2640371. View

11.

Eyers P, Liu J, Hayashi N, Lewellyn A, Gautier J, Maller J . Regulation of the G(2)/M transition in Xenopus oocytes by the cAMP-dependent protein kinase. J Biol Chem. 2005; 280(26):24339-46. DOI: 10.1074/jbc.M412442200. View

12.

Alto N, Soderling S, Hoshi N, Langeberg L, Fayos R, Jennings P . Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring. Proc Natl Acad Sci U S A. 2003; 100(8):4445-50. PMC: 153575. DOI: 10.1073/pnas.0330734100. View

13.

Diviani D, Dodge-Kafka K, Li J, Kapiloff M . A-kinase anchoring proteins: scaffolding proteins in the heart. Am J Physiol Heart Circ Physiol. 2011; 301(5):H1742-53. PMC: 3213966. DOI: 10.1152/ajpheart.00569.2011. View

14.

Dessauer C . Adenylyl cyclase--A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol. 2009; 76(5):935-41. PMC: 2774998. DOI: 10.1124/mol.109.059345. View

15.

Dessauer C, Scully T, GILMAN A . Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase. J Biol Chem. 1997; 272(35):22272-7. DOI: 10.1074/jbc.272.35.22272. View

16.

Dodge K, Khouangsathiene S, Kapiloff M, Mouton R, HILL E, Houslay M . mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001; 20(8):1921-30. PMC: 125429. DOI: 10.1093/emboj/20.8.1921. View

17.

Lester L, Coghlan V, Nauert B, Scott J . Cloning and characterization of a novel A-kinase anchoring protein. AKAP 220, association with testicular peroxisomes. J Biol Chem. 1996; 271(16):9460-5. DOI: 10.1074/jbc.271.16.9460. View

18.

Omar M, Scott J . AKAP Signaling Islands: Venues for Precision Pharmacology. Trends Pharmacol Sci. 2020; 41(12):933-946. PMC: 7890593. DOI: 10.1016/j.tips.2020.09.007. View

19.

Walker-Gray R, Stengel F, Gold M . Mechanisms for restraining cAMP-dependent protein kinase revealed by subunit quantitation and cross-linking approaches. Proc Natl Acad Sci U S A. 2017; 114(39):10414-10419. PMC: 5625894. DOI: 10.1073/pnas.1701782114. View

20.

Bain J, Plater L, Elliott M, Shpiro N, Hastie C, McLauchlan H . The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007; 408(3):297-315. PMC: 2267365. DOI: 10.1042/BJ20070797. View